CLINICAL ROLE -
Gilteritinib Prolongs Survival in Patients with FLT3-Mutated AML
Gilteritinib (Xospata) was superior to standard chemotherapy in improving overall survival in patients with acute myeloid leukemia.
Read More
Monday Pharmaceutical Mystery: April 1
Why did this patient's warfarin dose triple?
Trending News Today: CAR T Therapy Shows Early Promise for Use in Some Solid Tumors
Top news of the day from across the health care industry.
Pharmacists Play an Important Role in Managing Patients Taking Opioids With Benzodiazepines
Benzodiazepines are involved in over 30% of opioid overdoses. It is important to learn about this combination and how to counsel patients.
Clinical Trial Evaluating Novel HIV Vaccine Candidate
The IAVI WOO1 study is one of the first clinical trials of a native-like Env trimer and the first time that this particular trimer is being evaluated in humans
The Unusual Discovery of Commonly Prescribed Medications: Part 4
This article will describe the unusual discovery of 5 commonly prescribed medications, many of which were through serendipitous events.
First Short-Course Oral Therapy for Relapsing Forms of MS Granted FDA Approval
Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment.
First Short-Course Oral Therapy Approved for Relapsing Forms of MS
New Indication Approval Sought for Icosapent Ethyl
Study data suggest the drug helps reduce the risk of major adverse cardiovascular event in certain patients.
The iStopMM Trial & Importance of Early Screening
Watch
The Future of Oral Oncolytics
The Role of Payers in the Dispensing Process
Pearl 4: Using a Collaborative Care Plan for the Treatment of MM
Difficulties of the Multiple Myeloma Treatment Continuum
The Role of Specialty Pharmacies in the Dispensing Process
The Dispensing Capabilities of Pharmacies
Pearl 3: Avoiding Delays During Prior Authorization Process
The Risk Evaluation and Mitigation Strategies (REMS) Program
Pearl 1: Oral Parity Laws and Their Impact on Cost
Pearl 1: The Use of Co-Pay Cards to Solve an Economic Burden
Oral Oncolytic Treatment Options for Multiple Myeloma
Medicare Coverage of Oral Oncolytics
The Economic Burden of Multiple Myeloma Treatment
First-in-Human Clinical Trial Studying HIV Vaccine Candidate
The goals are to assess the candidate’s safety and to determine if the vaccination induces the human immune system to produce proteins called neutralizing antibodies.
April's Rosacea Awareness Initiative Emphasizes Benefits of Achieving Clear Skin
The National Rosacea Society (NRS) has designated April as Rosacea Awareness month to improve education of rosacea.
Immunotherapy for Pre-Cancerous Lesions May Reduce Skin Cancer Risk Over Time
The combination therapy reduced the risk of squamous cell carcinoma development on the face and scalp by approximately 75% in the study.
First Oral Drug for Secondary Progressive MS Tops SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
Trending News Today: Pharmacists, Dermatologists Counsel Differently on Topical Steroid Use
First Treatment for Non-Radiographic Axial Spondyloarthritis Granted FDA Approval
With this approval, certolizumab pegol becomes the first FDA-approved therapy for this type of axSpA, filling an unmet clinical need for treatment options, according to the release.
New CDC Guidance Recommends Artesunate as First-Line Treatment for Severe Malaria
The action follows discontinuation of quinidine, the only FDA-approved intravenous antimalarial drug in the United States.